Utilized for type 2 diabetes mellitus to manage blood glucose levels and support insulin response.
Mechanism of Action
Metformin reduces hepatic glucose production and improves insulin sensitivity. Glyburide stimulates the release of insulin from functioning pancreatic beta cells. Together, they provide synergistic control of fasting and postprandial glucose.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
12–24 hours
Contraindications
Severe renal impairment, Metabolic acidosis, Hypersensitivity to any component
Severe Adverse Events
Lactic acidosis, Hepatotoxicity, Severe hypoglycemia — requires immediate medical attention
Information related to Metformin with Glyburide is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
